BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
See today's BioWorld Asia
Home
» Samsung spearheads Korean efforts to develop MERS vaccine
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Samsung spearheads Korean efforts to develop MERS vaccine
Feb. 24, 2016
By
Haky Moon
No Comments
HONG KONG – South Korea's Samsung conglomerate is pouring tens of millions into Middle East respiratory syndrome (MERS) research, less than a year after an oversight at one of the company's hospitals facilitated the spread of the deadly virus.
BioWorld Asia